FDA Warning Letter Sent to Moy-Fincher Medical Group

Moy-Fincher Medical Group has received a warning letter form the Food and Drug Administration (FDA) following a review of its web site, www.dnaegfrenewal.com in December 2014. The product in question is DNA Eye Renewal, “appears to be promoted for conditions that cause the product to be drugs under section 201(g)(l)(C) of the Federal Food, Drug, and Cosmetic Act (the Act) [21 U.S.C. § 321(g)(1)(C)],” according to FDA’s letter, which was mailed in February.

According to the FDA document, examples of claims on the website include: 

• “Beta Glucan: Helps stimulate collagen production for added strength to the dermal matrix … “
• “Willowherb … control inflammation.”
• “Spanish Lavender … inhibit muscle fibers from contracting … “
• “Matrixyl3000 … stimulating the production of collagen, elastic, and hyaluronic acid and decreasing cell damage caused by glycation and inflammation.”
• “Tetrapeptide . .. mimic the activity of the youth hormone thymopoietin … reinforcing the cutaneous immune defenses in the skin … stimulate the growth of new cells in the epidermis.”